These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16410175)

  • 1. Compatibility of Gd-DTPA perfusion and histologic studies of the brain.
    Spencer RG; Fishbein KW; Cheng A; Mattson MP
    Magn Reson Imaging; 2006 Jan; 24(1):27-31. PubMed ID: 16410175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced delineation of white matter structures of the fixed mouse brain using Gd-DTPA in microscopic MRI.
    Kim S; Pickup S; Hsu O; Poptani H
    NMR Biomed; 2009 Apr; 22(3):303-9. PubMed ID: 19039800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
    Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
    Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
    Sonoda A; Nitta N; Ohta S; Nitta-Seko A; Murata S; Jo J; Tabata Y; Takahashi M; Tani T; Murata K
    J Magn Reson Imaging; 2009 Oct; 30(4):907-10. PubMed ID: 19787744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant.
    Chen G; Jespersen SN; Pedersen M; Pang Q; Horsman MR; Stødkilde-Jørgensen H
    Magn Reson Imaging; 2005 Jun; 23(5):685-9. PubMed ID: 16051044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
    Jin J; Teng G; Feng Y; Wu Y; Jin Q; Wang Y; Wang Z; Lu Q; Jiang Y; Wang S; Chen F; Marchal G; Ni Y
    Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements.
    Zhang HL; Ersoy H; Prince MR
    J Magn Reson Imaging; 2006 Mar; 23(3):383-7. PubMed ID: 16463306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents.
    Ivanusa T; Beravs K; Medic J; Sersa I; Sersa G; Jevtic V; Demsar F; Mikac U
    Phys Med; 2007 Dec; 23(3-4):85-90. PubMed ID: 18061121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
    Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH
    NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of perfusion fixation for improved neuropathologic examination.
    Adickes ED; Folkerth RD; Sims KL
    Arch Pathol Lab Med; 1997 Nov; 121(11):1199-206. PubMed ID: 9372749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety characteristics of gadobenate dimeglumine: clinical experience from intra- and interindividual comparison studies with gadopentetate dimeglumine.
    Shellock FG; Parker JR; Pirovano G; Shen N; Venetianer C; Kirchin MA; Spinazzi A
    J Magn Reson Imaging; 2006 Dec; 24(6):1378-85. PubMed ID: 17078095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
    Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
    Bueltmann E; Erb G; Kirchin MA; Klose U; Naegele T
    Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.
    Ito M; Ogino H; Oshima H; Shiraki N; Shibamoto Y; Kasai H; Mase M; Kawamura Y; Miyati T
    Magn Reson Imaging; 2006 Jun; 24(5):625-30. PubMed ID: 16735185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac phenotyping in ex vivo murine embryos using microMRI.
    Cleary JO; Price AN; Thomas DL; Scambler PJ; Kyriakopoulou V; McCue K; Schneider JE; Ordidge RJ; Lythgoe MF
    NMR Biomed; 2009 Oct; 22(8):857-66. PubMed ID: 19598179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.